# Abintus Bio, Inc. — Form D

Abintus Bio, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-08-16. The offering totals $15.7M, of which $13.7M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-08-16
- Form: D
- Accession: 0001942876-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.7M
- Amount sold: $13.7M
- Remaining: $2.0M
- Investors: 37
- Date of first sale: 2022-08-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-456036

## Issuer

- Name: Abintus Bio, Inc.
- CIK: 0001942876
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 10355 SCIENCE CENTER DRIVE, SUITE 250, SAN DIEGO, CA, 92121
- Phone: (858) 866-9795

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Nicholas A Boyle, Ph.D. | Director | San Diego, CA |
| Michael A Martin | Director | Toronto, A6 |
| Robert Anthony Williamson | Director | San Diego, CA |
| Troy E Wilson | Director | San Diego, CA |
| Nicholas A Boyle, Ph.D. | Executive Officer | San Diego, CA |
| Carlos E Ibanez | Executive Officer | San Diego, CA |

## More

- [CIK 1942876 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1942876&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001942876-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.